Showing results (1-10 of 257) with videos related to
Sort By:
Pageof 26
Recenti Progressi in Medicina|March 29, 2014
[Complete diagnostic work-up provides the rational basis for the most appropriate therapy of myelodysplastic syndromes]Fabrizio PaneAnnals of Hematology|May 11, 2026
Acquired bone marrow aplasia and long-lasting complete remission with Loncastuximab Tesirine in a patient with transformed marginal zone lymphoma: a case reportLorenzo Esposito, Ilaria Cappuccio, Fabrizio Pane, et al.Frontiers in Oncology|April 2, 2021
Dosing Strategies for Improving the Risk-Benefit Profile of Ponatinib in Patients With Chronic Myeloid Leukemia in Chronic PhaseFausto Castagnetti, Fabrizio Pane, Gianantonio Rosti, et al.Clinical Lymphoma, Myeloma & Leukemia|October 18, 2025
Intravascular Complications of Central Venous Catheterization in Chronic Hematological Diseases: Low Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Large StudyClaudia Giordano, Marco Picardi, Annamaria Vincenzi, et al.Haematologica|May 12, 2004
Prolonged molecular remission after autologous stem cell transplantation in relapsed acute promyelocytic leukemiaFelicetto Ferrara, Salvatore Palmieri, Mario Annunziata, et al.Expert Review of Hematology|November 19, 2010
New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemiaGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.Oncogene|December 12, 2002
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlationsFabrizio Pane, Mariano Intrieri, Concetta Quintarelli, et al.Annals of Hematology|November 29, 2019
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myelomaRosa Fonti, Sara Pellegrino, Lucio Catalano, et al.Hematological Oncology|September 22, 2006
Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical managementGiovanni Martinelli, Ilaria Iacobucci, Simona Soverini, et al.Frontiers in Immunology|September 12, 2022
Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndromeFabrizio Pane, Guillaume Lefevre, Namhee Kwon, et al.Pageof 26